Dr. Reddy's Laboratories has expanded its strategic partnership with South Korea's Sam Chun Dang Pharm into advanced liposomal drug formulations. While the collaboration is expected to strengthen its long-term growth pipeline, the stock has also entered a bullish technical phase after breaking above the ₹1,360 resistance level.
Read MoreDr. Reddy's Laboratories has expanded its strategic partnership with South Korea's Sam Chun Dang Pharm into advanced liposomal drug formulations. While the collaboration is expected to strengthen its long-term growth pipeline, the stock has also entered a bullish technical phase after breaking above the ₹1,360 resistance level.
Knack Packaging IPO GMP has surged to ₹35 on the final day of subscription, indicating an estimated listing price of ₹205 and a potential gain of over 20%.
HCL Tech has won a $1.14 billion AI and digital transformation contract, reportedly with Mercedes-Benz, boosting investor confidence. The deal strengthens revenue visibility, highlights the company's AI ambitions, and marks a significant competitive win in the IT services industry.
The NSE has lifted the restriction on YES Securities, the broking subsidiary of Yes Bank, allowing it to onboard new clients again. The ban, imposed in May 2026 over compliance issues, was revoked early after the company implemented corrective measures and cooperated with the exchange's verification process.
PB Fintech is set for a ₹1,909 crore block deal as MacRitchie Investments sells a 2.6% stake at a 4.6% discount. The transaction comes after the company reported strong Q4 FY26 earnings with 53.5% growth in net profit and 36.7% revenue growth.
Waterways Leisure Tourism shares rallied 10% to a fresh record high just a day after a disappointing stock market debut. Despite listing at a discount, the Cordelia Cruises operator attracted strong buying interest as investors looked beyond the subdued listing performance.
The Indian stock market extended its gains on July 2, 2026, with the Nifty closing at 24,175.70 and the Sensex rising 579 points. A strong rebound in IT stocks, lower Brent crude prices, easing US-Iran tensions, a stronger rupee, and lower India VIX boosted investor confidence, while Realty, Auto, Chemicals, Cement, and Consumer Durables also ended in positive territory.
Indian benchmark indices snapped a two-session losing streak on July 1, 2026, as the Nifty 50 climbed above the 24,000 mark and the Sensex gained 444 points. The rally was driven by easing crude oil prices, positive global cues, strong June auto sales, and broad-based buying in Realty, FMCG, Auto, and financial stocks, while IT remained under pressure amid concerns over slowing global technology spending.
The Indian stock market ended in the red on June 29, 2026, as renewed US-Iran tensions, higher crude oil prices, and profit booking weighed on investor sentiment. Nifty slipped to 23,946 while Sensex lost 372 points. Pharma stocks emerged as the top performers on biosimilar and export optimism, whereas Auto, IT, and Cement sectors witnessed broad-based selling amid cautious global cues.
Indian benchmark indices ended slightly higher on June 25, 2026, supported by easing Brent crude prices, a stronger rupee, and positive RBI commentary. Auto stocks led gains with strong rallies in Mahindra & Mahindra and Maruti Suzuki, while metal, oil & gas, and IT stocks remained under pressure. Lower market volatility and improving global sentiment helped sustain investor confidence.
The Indian stock market extended its gains on July 2, 2026, with the Nifty closing at 24,175.70 and the Sensex rising 579 points. A strong rebound in IT stocks, lower Brent crude prices, easing US-Iran tensions, a stronger rupee, and lower India VIX boosted investor confidence, while Realty, Auto, Chemicals, Cement, and Consumer Durables also ended in positive territory.
Indian benchmark indices snapped a two-session losing streak on July 1, 2026, as the Nifty 50 climbed above the 24,000 mark and the Sensex gained 444 points. The rally was driven by easing crude oil prices, positive global cues, strong June auto sales, and broad-based buying in Realty, FMCG, Auto, and financial stocks, while IT remained under pressure amid concerns over slowing global technology spending.
The Indian stock market ended in the red on June 29, 2026, as renewed US-Iran tensions, higher crude oil prices, and profit booking weighed on investor sentiment. Nifty slipped to 23,946 while Sensex lost 372 points. Pharma stocks emerged as the top performers on biosimilar and export optimism, whereas Auto, IT, and Cement sectors witnessed broad-based selling amid cautious global cues.
Indian benchmark indices ended slightly higher on June 25, 2026, supported by easing Brent crude prices, a stronger rupee, and positive RBI commentary. Auto stocks led gains with strong rallies in Mahindra & Mahindra and Maruti Suzuki, while metal, oil & gas, and IT stocks remained under pressure. Lower market volatility and improving global sentiment helped sustain investor confidence.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
